Literature DB >> 16178897

Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan.

P Auvinen1, R Tammi, M Tammi, R Johansson, V-M Kosma.   

Abstract

AIMS: To examine the expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in breast lesions, and to correlate it with the expression of hyaluronan (HA). METHODS AND
RESULTS: CD 44 expression was studied in 75 breast tissue samples, consisting of benign, premalignant and malignant breast lesions, using immunohistochemistry. CD 44 s, but not CD 44 v 3 or CD 44 v 6, was found in the stromal cells, and it was similar in benign and malignant tumours. In benign lesions CD 4 v 6 was detected in 20-30% of the ductal epithelial cells, while C 44 v 3 and CD 44 s were not expressed. CD 44 s, CD 44 v 3 and CD 44 v 6 were all up-regulated in the in situ carcinomas and invasive carcinomas. The level of CD 44 expression in carcinoma cells did not correlate with the type or differentiation of the tumours. CD 44 and HA expression levels were not closely linked in the benign or malignant breast lesions, because HA was overexpressed later in breast cancer progression than CD 44. However, in breast carcinomas CD 44 and HA positivity was often found in the same areas of the sections, and the dual staining confirmed actual colocalization of CD 44 s and HA in the same cells.
CONCLUSIONS: CD 44 s, CD 44 v 3 and CD 44 v 6 are up-regulated earlier than HA in breast carcinoma progression, and in later stages they often colocalize with cell surface HA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178897     DOI: 10.1111/j.1365-2559.2005.02220.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  24 in total

1.  Fish oil prevents breast cancer cell metastasis to bone.

Authors:  Chandi Charan Mandal; Triparna Ghosh-Choudhury; Toshi Yoneda; Goutam Ghosh Choudhury; Nandini Ghosh-Choudhury
Journal:  Biochem Biophys Res Commun       Date:  2010-10-28       Impact factor: 3.575

Review 2.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Christine A Earle; Weiliang Xia
Journal:  Cytoskeleton (Hoboken)       Date:  2011-11-29

Review 4.  Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige.

Authors:  Subhashis Natua; Cheemala Ashok; Sanjeev Shukla
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 5.  The role of breast cancer stem cells in metastasis and therapeutic implications.

Authors:  Marco A Velasco-Velázquez; Vladimir M Popov; Michael P Lisanti; Richard G Pestell
Journal:  Am J Pathol       Date:  2011-04-28       Impact factor: 4.307

Review 6.  Viewing hyaluronan: imaging contributes to imagining new roles for this amazing matrix polymer.

Authors:  Carol A de la Motte; Judith A Drazba
Journal:  J Histochem Cytochem       Date:  2011-03       Impact factor: 2.479

Review 7.  Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Authors:  Lilly Y W Bourguignon
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

8.  Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.

Authors:  Lilly Y W Bourguignon; Weiliang Xia; Gabriel Wong
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

9.  Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.

Authors:  Lilly Y W Bourguignon; Karine Peyrollier; Weiliang Xia; Eli Gilad
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

10.  The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.

Authors:  Sara R Hamilton; Shireen F Fard; Frouz F Paiwand; Cornelia Tolg; Mandana Veiseh; Chao Wang; James B McCarthy; Mina J Bissell; James Koropatnick; Eva A Turley
Journal:  J Biol Chem       Date:  2007-03-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.